HIV type-1 entry inhibitors with a new mode of action - PubMed (original) (raw)
HIV type-1 entry inhibitors with a new mode of action
Ryan C Fink et al. Antivir Chem Chemother. 2009.
Free article
Abstract
Background: The development of antiviral drugs has provided crucial new means to mitigate or relieve the debilitating effects of many viral pathogens. Regular use of these drugs has led to generation of resistant strains, making the control of many viral infections very difficult, particularly in HIV-seropositive and AIDS patients. A rich source for the discovery of new HIV infection inhibitors has been, and continues to be, the 'mining' of the large diversity of compounds already available in nature, and specifically those from botanical extracts.
Methods: Using a newly developed direct binding assay with mass spectrometry technology (direct analysis in real-time time-of-flight mass spectrometry), we were able to show that compounds present in extracts of elderberry, cinnamon and green tea bind to and block HIV type-1 (HIV-1) infection in target cells.
Results: The compounds that blocked HIV-1 infection were flavonoids and A-type proanthocyanidins. The 50% inhibitory concentration values of these extracts ranged from 0.5 to 201 microg/ml for four different HIV-1 serotypes. Interaction matrices with the elderberry extract and enfuvirtide, a peptide HIV-1 fusion inhibitor, revealed significant super additive effects. This indicates that the compounds in elderberry that prevent HIV-1 infection are likely to bind to viral glycoproteins other than gp41 (the binding site for enfuvirtide).
Conclusions: Optimized elderberry, green tea and cinnamon extracts rich in certain flavonoid compounds were shown to block HIV-1 entry and infection in GHOST cells. As such, these types of botanical extracts could provide a starting point for the development of possible safe and reliable cotherapies for HIV-1-positive individuals, as well as for the identification of new small molecules as leading drug candidates for HIV-1 therapeutics and microbicides.
Similar articles
- A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.
Yang J, Li L, Tan S, Jin H, Qiu J, Mao Q, Li R, Xia C, Jiang ZH, Jiang S, Liu S. Yang J, et al. Fitoterapia. 2012 Mar;83(2):348-55. doi: 10.1016/j.fitote.2011.11.016. Epub 2011 Dec 3. Fitoterapia. 2012. PMID: 22155187 - Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.
Ray N, Harrison JE, Blackburn LA, Martin JN, Deeks SG, Doms RW. Ray N, et al. J Virol. 2007 Apr;81(7):3240-50. doi: 10.1128/JVI.02413-06. Epub 2007 Jan 24. J Virol. 2007. PMID: 17251281 Free PMC article. - Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
Bianchi E, Finotto M, Ingallinella P, Hrin R, Carella AV, Hou XS, Schleif WA, Miller MD, Geleziunas R, Pessi A. Bianchi E, et al. Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12903-8. doi: 10.1073/pnas.0502449102. Epub 2005 Aug 29. Proc Natl Acad Sci U S A. 2005. PMID: 16129831 Free PMC article. - Inhibitors of viral entry.
Melby T, Westby M. Melby T, et al. Handb Exp Pharmacol. 2009;(189):177-202. doi: 10.1007/978-3-540-79086-0_7. Handb Exp Pharmacol. 2009. PMID: 19048201 Review. - Resistance to enfuvirtide, the first HIV fusion inhibitor.
Greenberg ML, Cammack N. Greenberg ML, et al. J Antimicrob Chemother. 2004 Aug;54(2):333-40. doi: 10.1093/jac/dkh330. Epub 2004 Jul 1. J Antimicrob Chemother. 2004. PMID: 15231762 Review.
Cited by
- Mechanism of PRRSV infection and antiviral role of polyphenols.
Amona FM, Pang Y, Gong X, Wang Y, Fang X, Zhang C, Chen X. Amona FM, et al. Virulence. 2024 Dec;15(1):2417707. doi: 10.1080/21505594.2024.2417707. Epub 2024 Oct 21. Virulence. 2024. PMID: 39432383 Free PMC article. Review. - Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins.
Maffei ME, Salata C, Gribaudo G. Maffei ME, et al. Molecules. 2022 Nov 30;27(23):8353. doi: 10.3390/molecules27238353. Molecules. 2022. PMID: 36500445 Free PMC article. Review. - Introduction to Traditional Medicine and Their Role in Prevention and Treatment of Emerging and Re-Emerging Diseases.
Rizvi SAA, Einstein GP, Tulp OL, Sainvil F, Branly R. Rizvi SAA, et al. Biomolecules. 2022 Oct 9;12(10):1442. doi: 10.3390/biom12101442. Biomolecules. 2022. PMID: 36291651 Free PMC article. Review. - A Review with Updated Perspectives on the Antiviral Potentials of Traditional Medicinal Plants and Their Prospects in Antiviral Therapy.
Saifulazmi NF, Rohani ER, Harun S, Bunawan H, Hamezah HS, Nor Muhammad NA, Azizan KA, Ahmed QU, Fakurazi S, Mediani A, Sarian MN. Saifulazmi NF, et al. Life (Basel). 2022 Aug 22;12(8):1287. doi: 10.3390/life12081287. Life (Basel). 2022. PMID: 36013466 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials